中文标题待翻译

Deeptech Funding Zooms 2.8X YoY In Q3 Despite Tighter Deal Flow
投看一句

中文翻译待补全

India’s deeptech startups raised substantially more capital in Q3 2026, even as the number of deals edged lower.

中文正文待翻译

deeptech funding Q3 2026

India’s deeptech startups raised substantially more capital in Q3 2026, even as the number of deals edged lower. 

As per Inc42’s ‘Indian Tech Startup Funding Report, Q3 2026’, deeptech startups raised $290 Mn across 28 deals, compared with $105 Mn across 29 deals in Q3 2025. The 176% YoY increase outpaced the broader startup ecosystem, where funding grew 5% to $2.2 Bn.

For context, deeptech startups are the ones that develop advanced technologies and hardware and include innovations across sub-segments like spacetech, robotics, defence technology and semiconductors.

Large Spacetech Rounds Drive Deeptech Funding Surge

The sharp rise in funding, despite a marginal decline in deal count, points to a concentration of capital in a smaller pool of startups. 

In this, large spacetech rounds accounted for a significant share of the funding deployed during the quarter, with the startups in the sector netting $130 Mn, accounting for about 45% of deeptech funding in Q3. Six-year-old spacetech startup Pixxel’s $100 Mn round was one of four mega funding rounds recorded during the quarter. The round accounted for over three-fourths of the segment’s total.

deeptech funding graphic

Sustaining this momentum will require capital to reach beyond a select group of companies. As per a recent report by the Indian Venture and Alternate Capital Association (IVCA), deeptech startups continue to face a funding gap at the Series B and C stages, with few funds equipped to write the larger cheques needed to take technologies from development to commercial scale.

IVCA President Rajat Tandon said bridging this gap, deepening domestic limited partner participation, and improving exit pathways will be critical to building globally competitive deeptech companies.

“India’s deeptech opportunity is moving from promise to more investible commitments, with an increasingly institutionalised ecosystem play. The growth in capital flowing into deeptech over the past decade reflects the confidence investors have in India’s scientific and technological capabilities. However, taking deeptech startups and entrepreneurs from the laboratory to global scale will require capital that is patient, appropriately structured, and available across the entire growth journey,” he said.

Government Push Adds To Deeptech Funding Momentum

Bharat Innovation Fund cofounder and partner Ashwin Raguraman attributed some of the recent momentum to the government’s ₹1 Lakh Cr Research, Development and Innovation (RDI) Fund and its wider push to support technology-led businesses.

“I attribute (growth in deeptech funding) this quarter and maybe even last quarter predominantly due to the announcement on the government’s deeptech-focused ₹1 Lakh Cr RDI Fund and a fairly solid government push, which is making capital available to VC funds,” Raguraman told Inc42.

The RDI Fund aims to catalyse private investment in research-intensive businesses. Its framework includes eligibility requirements for R&D-intensive technologies at technology readiness level (TRL) 4 or above, indicating that they have progressed beyond basic laboratory validation.

New investment vehicles also emerged during the quarter. Asiana Fund and JC Capital jointly launched a ₹1,000 Cr deeptech fund, while Transition VC and Accel launched funds to back technology-led businesses.

RDI Fund Faces Questions Over Governance

However, the extent to which the RDI Fund has influenced investor sentiment remains uncertain. In August, The Indian Express reported that nearly two-thirds of the more than ₹2,000 Cr allocated to deeptech companies under the scheme had gone to firms with links to members of the panel involved in selecting beneficiaries, raising concerns over potential conflicts of interest.

Inc42’s Q3 2026 Indian Investor Ranking & Sentiment Survey, which covered 85 institutional investors, found that 52% considered disclosure and recusal safeguards adequate but said visibility remained limited. 

Another 25% viewed the issue as a governance failure requiring independent oversight, while 14% said such investment ties could be managed through disclosure and recusal. The remaining 9% said it was not a concern, arguing that the focus should remain on company selection.

The findings suggest that the availability of government-backed capital is only part of the equation. Transparency in its allocation and the availability of patient capital across funding stages will also shape the sector’s ability to turn promising technologies into globally competitive businesses.

The post Deeptech Funding Zooms 2.8X YoY In Q3 Despite Tighter Deal Flow appeared first on Inc42 Media.

投资人评论

聊判断,不堆黑话

登录且账号审核通过后可评论。 立即登录